Orient Europharma Co Ltd (4120) — Cash Flow Quality Index
Orient Europharma Co Ltd (4120) has a Cash Flow Quality Index of 6.11x as of September 2024. Operating cash flow of NT$69.52 Million exceeds net income of NT$11.38 Million, indicating high earnings quality where cash backs reported profits. Explore 4120 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Orient Europharma Co Ltd Cash Flow Quality Index (2015–2023)
Historical Cash Flow Quality Index for Orient Europharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 4120 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Orient Europharma Co Ltd (2015–2023)
Year-by-year earnings quality comparison for Orient Europharma Co Ltd. For live market cap and the full company financial profile, see 4120 market cap overview.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.45x | NT$64.67 Million | NT$143.94 Million | ▼ -30.5% |
| 2021 | 0.65x | NT$77.65 Million | NT$120.17 Million | ▼ -78.8% |
| 2020 | 3.05x | NT$608.55 Million | NT$199.30 Million | ▲ +232.6% |
| 2019 | 0.92x | NT$227.37 Million | NT$247.66 Million | ▼ -2.1% |
| 2018 | 0.94x | NT$231.31 Million | NT$246.74 Million | ▼ -28.5% |
| 2017 | 1.31x | NT$601.08 Million | NT$458.73 Million | ▲ +453.2% |
| 2016 | 0.24x | NT$111.24 Million | NT$469.61 Million | ▼ -91.8% |
| 2015 | 2.89x | NT$643.97 Million | NT$223.16 Million | — |